Solt DB Biotech Company DB /
CRISPR Therapeutics

CRISPR Therapeutics

Operating Overview

Year Founded

2013

Country

United States

Operating Status

Active

Genesis

Spinout (Academic)

Former Name(s)

Incubator or Accelerator

Taxonomy

Bioeconomy Sector

Biopharma

Sector Focus

Drug Development

Tags

Autologous

CAR-T

CRISPR

Delivery (Nanoparticles)

Ex vivo

Gene Editing

Genetic Medicines

Synthetic Biology

Equity Type

Public

Stock Symbol

Nasdaq: CRSP

Explore